PGEN News and Press, Precigen Inc. From 08/08/23

2023-08-08 10:46:10 ET Major earnings expected before the bell on Wednesday include: Brookfield Asset Management ( BAM ) 3D Systems ( DDD ) PENN Entertainment ( PENN ) Roblox ( RBLX ) Sony Group ( SONY ) For further details see: Notable ea...

Precigen to Announce Second Quarter and First Half 2023 Financial Results on August 9th PR Newswire GERMANTOWN, Md. , Aug. 3, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene an...

Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis PR Newswire – First FDA Breakthrough Therapy Designation granted for AdenoVerse immunotherapy platform; designatio...

2023-06-08 12:15:22 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group –  By utilizing newly developed novel mechanisms, biotech researchers and scientists are making strides in the battle aga...

2023-06-06 08:34:13 ET Summary Precigen's Q1 2023 financial report shows a decrease in revenue and sustained operating losses, but the company is making progress in several clinical programs, particularly PRGN-2012 and PRGN-2009. PRGN-2012 immunotherapy shows promise for treating ...

Precigen Announces Positive Phase 1 Data for PRGN-3005 Autologous UltraCAR-T® Cells Manufactured Overnight for Infusion Next Day to Advanced Stage Platinum Resistant Ovarian Cancer Patients PR Newswire – PRGN-3005 was well-tolerated with no dose limiting toxicities...

Precigen Announces Positive Phase 1 Data for Off-the-Shelf PRGN-2009 AdenoVerse™ Immunotherapy Alone and in Combination with an Investigational Checkpoint Inhibitor in Patients with Recurrent/Metastatic HPV-associated Cancers PR Newswire – PRGN-2009 combined with...

Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study of PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy in Combination with Pembrolizumab to Treat Patients with Recurrent or Metastatic Cervical Cancer PR Newswire – HPV is responsible for more than 90 p...

2023-05-19 06:40:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips High-risk penny stocks have long tempted investors with the potential for significant returns. However, it is crucial to acknowledge the inherent risks associated with these speculative...

2023-05-10 14:59:05 ET Precigen, Inc. (PGEN) Q1 2023 Earnings Conference Call May 10, 2023 08:00 ET Company Participants Steve Harasym - Vice President, Investor Relations Helen Sabzevari - President & Chief Executive Officer Harry Thomasian - Chief Financial...